Zemuron and Nausea - a phase IV clinical study of FDA data

Summary:

Nausea is reported as a side effect among people who take Zemuron (rocuronium bromide), especially for people who are male, 60+ old, also take Diprivan, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Nausea when taking Zemuron. It is created by eHealthMe based on reports of 872 people who have side effects when taking Zemuron from the FDA, and is updated regularly.

What is Zemuron?

Zemuron has active ingredients of rocuronium bromide. eHealthMe is studying from 873 Zemuron users. Check the latest studies of Zemuron.

What is Nausea?

Nausea (feeling of having an urge to vomit) is found to be associated with 3,859 drugs and 5,629 conditions by eHealthMe. Check the latest studies of Nausea.

On Mar, 03, 2026

872 people reported to have side effects when taking Zemuron.
Among them, 27 people (3.1%) have Nausea.

Among these 27 people:

What is the gender of people who have Nausea when taking Zemuron? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Nausea when taking Zemuron? *

What are other drugs people take besides Zemuron? *

Diprivan: 20 people, 74.07%
Pepcid: 14 people, 51.85%
Versed: 14 people, 51.85%
Robinul: 14 people, 51.85%
Lidocaine: 12 people, 44.44%
Fentanyl Citrate: 11 people, 40.74%
Morphine: 10 people, 37.04%
Zantac: 9 people, 33.33%
Meperidine Hydrochloride: 9 people, 33.33%
Zofran: 9 people, 33.33%

What are other side effects people have besides Nausea? *

Abdominal Pain: 13 people, 48.15%
Mitral Valve Incompetence (inefficient heart valve): 13 people, 48.15%
Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 9 people, 33.33%
Anaemia (lack of blood): 9 people, 33.33%
Oral Herpes (viral infection of mouth): 9 people, 33.33%
Belching (release of gas from the digestive tract): 9 people, 33.33%
Dyslipidaemia (abnormal amount of lipids): 9 people, 33.33%
Pain: 9 people, 33.33%
Diabetes: 9 people, 33.33%
Ventricular Hypertrophy (enlargement of ventricles (lower chambers) in the heart): 9 people, 33.33%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 14.81%
Postoperative Ileus: 2 people, 7.41%
Procedural Pain: 1 person, 3.70%
Depression: 1 person, 3.70%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 3.70%
Bone Disorder: 1 person, 3.70%
Application Site Anaesthesia: 1 person, 3.70%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Zemuron and have Nausea?

- Check whether Nausea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zemuron:

Zemuron (873 reports)

Nausea treatments and more:

Nausea (962,085 reports)

Browse all side effects of Zemuron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nausea:

Nausea (3,859 drugs)

Browse all the conditions that are associated with Nausea:

Nausea (5,629 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rocuronium bromide (the active ingredients of Zemuron) and Zemuron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.